tisotumab vedotin
GCT1015-06
Phase 2 small_molecule completed
Quick answer
tisotumab vedotin for Solid Tumor is a Phase 2 program (small_molecule) at Genmab A/S with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Genmab A/S
- Indication
- Solid Tumor
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed